Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5209316
Max Phase: Preclinical
Molecular Formula: C22H16N2O4
Molecular Weight: 372.38
Associated Items:
ID: ALA5209316
Max Phase: Preclinical
Molecular Formula: C22H16N2O4
Molecular Weight: 372.38
Associated Items:
Canonical SMILES: O=C(/C=C/c1cccc([N+](=O)[O-])c1)c1ccc(NC(=O)c2ccccc2)cc1
Standard InChI: InChI=1S/C22H16N2O4/c25-21(14-9-16-5-4-8-20(15-16)24(27)28)17-10-12-19(13-11-17)23-22(26)18-6-2-1-3-7-18/h1-15H,(H,23,26)/b14-9+
Standard InChI Key: GQGMDGXQJSWKKT-NTEUORMPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 372.38 | Molecular Weight (Monoisotopic): 372.1110 | AlogP: 4.74 | #Rotatable Bonds: 6 |
Polar Surface Area: 89.31 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.92 | CX LogD: 4.92 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.29 | Np Likeness Score: -1.13 |
1. Chitre S, Ray AM, Stevens M, Doud EH, Liechty H, Washburn A, Tepper K, Sivinski J, O'Hagan HM, Georgiadis MM, Chapman E, Johnson SM.. (2022) Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol., 75 [PMID:36356534] [10.1016/j.bmc.2022.117072] |
Source(1):